Enberg D: A communityrandomized evaluation with the effect of intermittent preventive therapy in infants on antimalarial drug resistance in southern Tanzania. J Infect Dis 2013, 207:84859. Iriemenam NC, Shah M, Gatei W, van Eijk AM, Ayisi J, Kariuki S, Vanden EJ, Owino SO, Lal AA, Omosun YO, Otieno K, Desai M, ter Kuile FO, Nahlen B, Moore J, Hamel MJ, Ouma P, Slutsker L, Shi YP: Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant females in western Kenya. Malar J 2012, 11:134. Raman J, Little F, Roper C, Kleinschmidt I, Cassam Y, Maharaj R, Barnes KI: 5 years of large-scale dhfr and dhps mutation surveillance following the phased implementation of artesunate plus sulfadoxine-pyrimethamine in Maputo Province, Southern Mozambique. Am J Trop Med Hyg 2010, 82:78894. Doumbo S, Ongoiba OA, Doumtabe D, Dara A, Ouologuem TD, Kayentao K, Djimde A, Traore B, Doumbo OK: [Prevalence of Plasmodium falciparum, anemia and molecular markers of chloroquine and sulfadoxinepyrimethamine resistance in delivered girls in Fana, Mali] (in French). Bull Soc Pathol Exot 2013, 106:18892. Duah NO, Quashie NB, Abuaku BK, Sebeny PJ, Kronmann KC, Koram KA: Surveillance of molecular markers of Plasmodium falciparum resistance to sulphadoxine-pyrimethamine 5 years soon after the modify of malaria therapy policy in Ghana. Am J Trop Med Hyg 2012, 87:996003. Ndiaye M, Tine R, Faye B, Ndiaye JL, Diouf I, Lo AC, Sylla K, Dieng Y, Hallett R, Alifrangis M, Gaye O: Selection of antimalarial drug resistance soon after intermittent preventive therapy of infants and young children (IPTi/c) in Senegal. C R Biol 2013, 336:29500. Allen EN, Small F, Camba T, Cassam Y, Raman J, Boulle A, Barnes KI: Efficacy of sulphadoxine-pyrimethamine with or without having artesunate for the therapy of uncomplicated Plasmodium falciparum malaria in southern Mozambique: a randomized controlled trial.Oleandrin Cancer Malar J 2009, eight:141.CCT373566 Formula Gutman J, Mwandama D, Wiegand RE, Ali D, Mathanga DP, Skarbinski J: Effectiveness of intermittent preventive therapy with sulfadoxinepyrimethamine in the course of pregnancy on maternal and birth outcomes in Machinga district, Malawi.PMID:35670838 J Infect Dis 2013, 208:90716. Taylor SM, Antonia AL, Chaluluka E, Mwapasa V, Feng G, Molyneux ME, ter Kuile FO, Meshnick SR, Rogerson SJ: Antenatal receipt of sulfadoxinepyrimethamine does not exacerbate pregnancy-associated malaria in spite of the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study. Clin Infect Dis 2012, 55:420. Eisele TP, Larsen DA, Anglewicz PA, Keating J, Yukich J, Bennett A, Hutchinson P, Steketee RW: Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa. Lancet Infect Dis 2012, 12:94249. WHO-MPAC: Malaria Policy Advisory Committee towards the WHO: conclusions and recommendations of March 2013 meeting. Malar J 2013, 12:213. Lin JT, Mbewe B, Taylor SM, Luntamo M, Meshnick SR, Ashorn P: Enhanced prevalence of dhfr and dhps mutants at delivery in Malawian pregnant women getting intermittent preventive remedy for malaria. Trop Med Int Wellness 2013, 18:17578. Laufer MK, Thesing Pc, Eddington ND, Masonga R, Dzinjalamala FK, Takala SL, Taylor TE, Plowe CV: Return of chloroquine antimalarial efficacy in Malawi. N Engl J Med 2006, 355:1959966.Matondo et al. Malaria Journal 2014, 13:152 http://www.malariajournal/content/13/1/Page 7 of37. Mohammed A, Ndaro A, Kalin.